Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1

Conditions

Multiple Myeloma 7Neoplasms, Plasma Cell 5Breast Neoplasms 4Pain 2Neoplasm Metastasis 2Prostatic Neoplasms 1

Interventions

Gemcitabine 74Capecitabine 60Paclitaxel 59Fluorouracil 58Oxaliplatin 57Bevacizumab 51Docetaxel 50Leucovorin 48Nivolumab 40Cisplatin 40Irinotecan 39Carboplatin 37Cetuximab 34pembrolizumab 32Radiosurgery 32Trastuzumab 30Radiotherapy 27Everolimus 24Sorafenib 23Pemetrexed 20Doxorubicin 20Albumin-Bound Paclitaxel 20Ipilimumab 19Cyclophosphamide 19Panitumumab 18Zoledronic Acid 17Lapatinib 17Erlotinib Hydrochloride 17Prednisone 16pazopanib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasm Metastasis × Pamidronate × Clear all
NCT00128297 2023-03-28

Pamidronate Administration in Breast Cancer Patients With Bone Metastases

Spanish Breast Cancer Research Group

Phase 4 Completed
152 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02721433 2020-12-02

REaCT-BTA

Ottawa Hospital Research Institute

Phase 4 Completed
263 enrolled
BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡